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Abstract
2YHUWKHSDVWIHZ\HDUVDZDUHQHVVRIWKHSUHYDOHQFHRIREVWUXFWLYHVOHHSDSQHDKDVVLJQLÀFDQWO\LQFUHDVHG,QGHHGVOHHSDSQHD
may be more common now with the increasing incidence of obesity and the growing number of elderly individuals in our population. How serious is this condition, and what are the potential long-term effects and consequences of obstructive sleep apnea
if left untreated? An overlap of many serious conditions with obstructive sleep apnea has been noticed. These conditions include
hypertension, heart disease and failure, stroke, diabetes, neurological diseases, depression, and a number of other serious health
concerns. The purpose of this paper is to understand what the effects of untreated obstructive sleep apnea might be, and to
GHWHUPLQHLILVUHDVRQDEOHWRVXJJHVWWKDWVOHHSDSQHDLVWKHFDXVHRIRUDWOHDVWDVLJQLÀFDQWFRQWULEXWLQJIDFWRUWRWKHFRQGLWLRQV
LWLVDVVRFLDWHGZLWK5HVHDUFKVKRZVWKDWVOHHSDSQHDLWVHOIGRHVLQÁLFWHQRUPRXVWUDXPDRQWKHERG\7KLVWUDXPDLVPDLQO\LQ
WKHIRUPVRIK\SR[LDZKLFKOHDGVWRR[LGDWLYHVWUHVVYDVFXODUGDPDJHDQGK\SHUVWLPXODWLRQRIWKHV\PSDWKHWLFQHUYRXVV\VWHP
which can lead to high blood pressure and subsequent heart disease and failure, and by causing repeated episodes of unnatural
LQWUDWKRUDFLFSUHVVXUHZKLFKFDQOHDGWRDQXPEHUVHULRXVKHDOWKFRQFHUQVDQGHYHQVXGGHQGHDWK7KHVHÀQGLQJVGHPRQVWUDWH
that sleep apnea should not be viewed as an incidental condition alongside other serious health problems nor mainly as a side
effect of them. It should rather be seen as a contributing factor, if not the primary cause, of many consequential health issues.
Introduction

Methods

Untreated obstructive sleep apnea has been strongly linked to
many serious diseases and early mortality. It can be the underlying cause of certain diseases, and it can cause rapid progression
or early onset of others. Perhaps even more alarming, is that
many incidences of sudden death, especially heart attacks, have
been attributed to untreated obstructive sleep apnea. The basic
understanding of its severity is that untreated obstructive sleep
DSQHDLQÁLFWVVLJQLÀFDQWDQGPXOWLIDFHWHGWUDXPDRQWKHERG\
This trauma is mainly due to nightly deprivation of oxygen in
the blood, sleep deprivation, constant hyper stimulation of the
sympathetic nervous system, and enormous strain on the heart.
It is noteworthy that there are also secondary physical, mental,
and emotional health concerns associated with untreated sleep
apnea. In a random sample of several hundred individuals presenting to a sleep clinic with symptoms typical of sleep apnea,
it was observed that the vast majority of the patients subsequently diagnosed with obstructive sleep apnea had at least
one other serious health issue. The percentage of people with
additional health problems tended to be much higher among
those 40 years of age and older- i.e. in the individuals who had
gone through many more years of trauma to their bodies before
seeking treatment (personal observation, Chang, et.al. 2013).
It is also especially critical to explore the effects of untreated sleep apnea because it effects many more people than was
previously thought (up to 24% of adult men) (Peppard, et.al.
2000) and because there has been a steady rise in the diagnosis of sleep apnea with the increased incidence of obesity. In
addition to the obesity factor, it is now known that the general
aging process is a major risk factor in the development of sleep
apnea. Consequently, it may be prudent to study the diagnostic methods and treatment options for sleep apnea for those
involved in geriatric care (Adegunsoye, Ramachandran, 2012).
Several studies indicate that post-menopausal women are at
increased risk for developing obstructive sleep apnea because
the female sex hormones which help dilate the airway decrease
after menopause (Chang, et.al. 2013).This paper will explore the
question of how untreated sleep apnea effects the body and the
implications of these effects.

Relevant material was scoured mainly from the web, from conversations and correspondence with a veteran pulmonologist
and sleep specialist, and from personal experience observing
and interviewing patients and studying polysomnography data at
a sleep clinic over a period of about two months. Only materials
from authoritative sources were used. An effort was made to
gather information on the interaction between sleep apnea and
numerous medical conditions thus broadening the scope of the
paper. This was done in order get as full a picture as possible on
how sleep apnea may affect the body. Material on the effectiveness of treatment of sleep apnea was also considered pertinent
to understanding the mechanisms of this condition and are included in the discussion accordingly.
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'HÀQLWLRQRI7HUPV
6OHHSDSQHD6OHHSDSQHDLVGHÀQHGDVDFHVVDWLRQRIEUHDWKLQJ
of ten seconds or more while asleep (Tsara, et.al. 2009). There
are two main types of sleep apnea: Obstructive Sleep Apnea, and
Central Sleep Apnea.
Obstructive Sleep Apnea (OSA): OSA is an anatomical condition where, while asleep, the muscles in the throat relax to an
H[WHQWWKDWWKHDLUZD\FROODSVHV6SHFLÀFDOO\WKHUHPD\EHVHYeral different muscles responsible for this. Sleep apnea is more
common in people who have a narrow airway. A narrow airway
FDQEHJHQHWLFLWFDQEHFDXVHGE\LQÁDPPDWLRQRULWFDQEH
due to obesity. (Obese individuals often have excess submucosal
adipose tissue which can build up around the airway thereby
causing the airway to compress.) Defects in, or damage to, the
face or neck in areas which affect the airway may also be a risk
factor for OSA. OSA can affect adults or children, but is more
common in adults (Tsara, et.al. 2009). OSA can be a factor in determining the cause of Sudden Infantile Death Syndrome (SIDS),
and a family history of OSA may be considered a risk factor in
SIDS (Thach, 2008).
Central Sleep Apnea (CSA): CSA is a condition where the
apneustic center in the brain stem fails to send nerve impulses
necessary for breathing. CSA can occur without an obstructed airway. However, OSA and CSA are often clinically related.
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When a patient who has CSA and OSA is treated just for the
OSA, the CSA part of the sleep apnea is often minimized or
even eliminated (Costanzo, et.al. 2015). It is possible that the
disordered breathing caused by the OSA may contribute to the
apneustic center malfunction- either directly or by a secondary
mechanism. CSA can also be accompanied by irregular breathing patterns. For example, the Cheyne-Stokes respiration is a
common symptom of primary CSA (Tsara, et.al. 2009, Costanzo,
et.al. 2015). (Cheyne-Stokes respiration is a breathing pattern
where there are rapid or deep breaths followed by a decrease
and secession of breathing. This is usually in a cycle which can
last anywhere from 30 seconds to two minutes.) CSA can also
be secondary to illness or trauma, and it can be caused by
certain medications and substances. It is noteworthy that if a
newborn has sleep apnea, it is often CSA (Tsara, et.al. 2009) and
may be a factor in determining the cause of SIDS (Thach, 2008).
Hypopnea: A hypopnea is a partial closure of the airway which
is often characterized by loud snoring. (The snoring is caused
E\WKHÁXWWHULQJRIWKHDLUSDVVDJHZDOOVDVWKH\FRPHLQFORVH
SUR[LPLW\ ZKLOH EUHDWKLQJ 7KLV SDUWLDO FORVLQJ LV FODVVLÀHG DV
a hypopnea when the obstruction is severe enough to cause
oxygen desaturation in the blood.
Polysomnography: A polysomnography is a sleep study. During
a sleep study, the individual is attached to electrodes and other
machinery which collect information about the person’s sleep.
This information will include how long the patient spent in each
phase of sleep, whether or not the patient has OSA or CSA, oxygen saturation or desaturation in the blood, breathing patterns,
and many other items of relevance. A polysomnography can be
used to diagnose sleep apnea.
Apnea-Hypopnea Index (AHI): An AHI is a score of how many
events of apnea and hypopnea occur per hour. For example, if
six times in the course of an hour, a patient stops breathing for
ten seconds or more and/or has an oxygen desaturation, then
the patient will have an AHI of 6 (or an event on average of
every ten minutes).
Sleep Disordered Breathing: Sleep disordered breathing is a
general term used to refer to any abnormal breathing issues
or abnormal breathing patterns which can occur when one is
asleep.
Continuous Positive Airway Pressure Machine (CPAP
Machine): A CPAP Machine is a medical device which blows air
through the nose to the back of the airway to keep it open while
a person is asleep. It is currently the most effective standard
treatment for sleep apnea.The machine can be adjusted to apply
more or less pressure as needed, and modern machines are
often self-adjusting. Other machines are available to treat more
complicated cases, but they too incorporate positive pressure
to treat the OSA component of any sleep disordered breathing.
There are surgeries which can be performed to help eliminate
OSA, but they are only about 50% effective. Some dental devices

have been developed to treat OSA, but they too are often insufÀFLHQWDVHIIHFWLYHWUHDWPHQW 3HNHUHWDO 

Discussion
The most obvious area of concern with sleep apnea is the fact
that when breathing stops, oxygen doesn’t enter the lungs.
This, in turn, leads to oxygen desaturation in the blood. This
hypoventilation has been linked to a number of conditions such
as systemic hypertension (Peppard, et.al. 2000), pulmonary hypertension (average pressure in the pulmonary arteries greater
than 25mmHg (resting)) (Adegunsoye, Ramachandran, 2012),
polycythemia (high red blood cell count), heart problems, behavioral issues, emotional issues (Sheu, et.al. 2015), and birth
defects (Tsara, et.al. 2009, Adegunsoye, Ramachandran, 2012).
It has also been reported that early treatment is effective in
eliminating these negative effects, and it is therefore of paramount importance to recognize, diagnose, and treat sleep apnea
syndrome at the earliest possible opportunity (Adegunsoye,
Ramachandran, 2012).
Systemic hypertension can be due to numerous factors involving OSA. One factor is that the hypoxia may lead to a pressor
effect as an attempt by the body to get more oxygen (Peppard,
et.al. 2000, Tkacova, et.al. 2014). Another contributing factor to
K\SHUWHQVLRQLVÁXLGDQGVRGLXPUHWHQWLRQGXHWRV\PSDWKHWLF
nervous system activation of the renin angiotensin aldosterone
system effecting the kidneys (Bradley, Floras, 2003, Nishizaka,
et.al. 2004). Many patients with untreated OSA have swelling in
their legs (personal observation). It is noteworthy that administration of oxygen does not prevent the hypertensive effect of
untreated OSA (Leung, Bradley, 2001).
The increased risk for developing hypertension due to untreated OSA is present even in individuals diagnosed with mild
sleep apnea (AHI of approx. 5) (Peppard, et.al. 2000). The risk
for developing hypertension is, however, directly related to the
severity of the sleep apnea. Several studies show that individuals with more severe sleep apnea were more likely to develop
hypertension than those with milder sleep apnea (Peppard, et.al.
2000, Peker, et.al. 2002, Nieto, et.al. 2000). The likelihood of developing hypertension is present regardless of gender, race, or
ethnicity, and it is usually manifest in individuals middle age or
older (Nieto, et.al. 2000). Severity of sleep apnea is based on AHI
and on ODI (oxygen desaturation index) (Tkacova, et.al. 2014).
If treatment for OSA is initiated before the onset of hypertension, then chronic hypertension as well as other cardiovascular
disease may be avoided. Additionally, treatment for the OSA has
a much greater impact on lowering blood pressure than does
weight loss (Nieto, et.al. 2000, Tkacova, et.al. 2014, Lavie, et.al.
2000). Even in the event that hypertension has already set in,
VWXGLHVVKRZWKDWLWFDQEHPLQLPL]HGVLJQLÀFDQWO\DIWHUDSSUR[imately 9 weeks of treatment (Milleron, et.al. 2004). The association between sleep apnea and hypertension is so strong that
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sleep apnea should be seriously considered in the diagnosis and
treatment of high blood pressure (Lavie, et.al. 2000).
Many studies have demonstrated that endothelial cells are
severely damaged and impaired by hypoxic conditions, and
the extent of endothelial cell damage has also been associated
with the AHI index (Lui, et.al. 2013). The damage may occur in
the form of apoptosis of endothelial cells, in the form of cell
cycle arrest, and in a number of other ways which play a role in
many of the adverse effects of untreated sleep apnea (Iida, et.al.
2002). Endothelial cell damage and dysfunction is connected to
LQÁDPPDWLRQDWKHURVFOHURVLVUHQDOGDPDJHLPSDLUHGYDVRGLODtion ability and nitric oxide production, and many other severe
health issues (Bruno, et.al. 2013). Additionally, oxidative stress
seems to be one of the main causes for endothelial cell damage.
The extent of oxidative stress is likewise directly correlated to
the severity of the sleep apnea (Del ben, et.al. 2012). It is extremely important to realize that the individual with untreated
OSA is at increased risk of arterial stiffness, which can lead to
heart disease and other severe health issues even if they experience very minimal symptoms (Kohler, et.al. 2008).
Hypoxia is known to cause an increase in reactive oxygen
species. The mechanism for this phenomenon is not clear, but
some studies suggest that this is due to the lack of a strong
electron acceptor in the absence of oxygen. When there are no
electron acceptors, the electrons have no place to go and therefore remain unbound as superoxide radicals or as other reactive oxygen species (ROS) (Kondoh, et.al. 2013). Compounding
this problem is the reperfusion following the apneic episode
which also causes an increase in ROS. Reperfusion may cause
an increase in ROS for two reasons. One is that cell function
has been impaired due to the lack of oxygen and is altogether
QRWUXQQLQJHIÀFLHQWO\HQRXJKWRULGLWVHOIRIWKH5266HFRQG
LV WKDW WKH VXGGHQ LQÁX[ RI R[\JHQ RYHUORDGV WKH FHOO ZKLFK
cannot process it fast enough. Studies show that hypoxia and
subsequent reperfusion can cause damage to the epithelial lining of blood vessels.This damage can cause and/or contribute to
atherosclerosis (Sawatari, et.al. 2016).
Aside from the ROS caused by reperfusion, there are other
ROS released by a number of granular leukocytes in response
to hypoxemia. The increased presence of ROS is a general
danger to the body and has been linked to cancer and other
illnesses.This is especially a concern for cancers which originate
in endothelial cells because they are most directly affected by
ROS (Kondoh, et.al. 2013). This is especially the case when the
body experiences this kind of oxidative stress night after night
for years on end (Adegunsoye, Ramachandran, 2012, Milleron,
et.al. 2004). Proper treatment of OSA solves the problem of
oxidative stress and can help reverse some or all of the damage
caused by it (Del ben, et.al. 2012, Bayram, et.al. 2009).
Pulmonary hypertension in particular, is one cause for right
sided heart failure and has an especially grim prognosis if left

38

untreated. Pulmonary hypertension can be caused by a number
of conditions, but its link to OSA and general sleep disordered
breathing is strong enough that the American College of Chest
Physicians recommends that patients presenting with pulmonary hypertension be evaluated for sleep disordered breathing.
The pathophysiology of pulmonary hypertension in sleep disordered breathing is that the hypoxia caused by the breathing
disorder in turn causes hypertrophy of the pulmonary arteries.
This hypertrophy decreases perfusion of blood in the lungs.The
situation is even more disastrous for individuals with emphyVHPDRUÀEURVLVRIWKHOXQJ7KHKHDUWWULHVWRFRPSHQVDWHIRU
the decrease in perfusion by working harder, and this attempted
compensation puts enormous strain on the right ventricle. This
strain is unsustainable and leads to right sided heart failure and a
subsequent general dyspnea even at rest. If left untreated, death
typically occurs within three years of diagnosis (Adegunsoye,
Ramachandran, 2012). The mechanism of how hypoxia causes
the initial hypertrophy of the pulmonary arteries needs elucidation, but it seems to be related to endothelial cell dysfunction.
(It is also noteworthy that obese individuals are more likely
to develop pulmonary hypertension with OSA (Adegunsoye,
Ramachandran, 2012).)
Aside from hypertrophy of the pulmonary arteries which
can cause pulmonary hypertension, there is the direct effect
of hypoxia in the form of pulmonary vasoconstriction. The reason for vasoconstriction during an hypoxic event is due to an
attempt by the body to keep ventilation and perfusion in sync.
In the absence of oxygen, vasoconstriction will lessen perfusion.
This, however, will also cause an increase in pulmonary artery
pressure. This pressure is primarily a concern while the individual is sleeping. However, about 20% of patients with elevated
pulmonary artery pressure while sleeping will eventually develop pulmonary hypertension even while awake. This may be because the increased blood pressure can directly cause damage
to blood vessels and result in the hardening and stenosis of
those damaged vessels.
Another area of concern in untreated OSA is the effect of
prolonged sympathetic nervous system stimulation. When
a person with OSA has an event, the body responds to the
REVWUXFWHGEUHDWKLQJE\DFWLYDWLQJWKHÀJKWRUÁLJKWUHVSRQVH
This occurs for each event- all night, every night. One effect of
this stimulation is vasoconstriction and an increased heart rateboth of which raise blood pressure. Eventually, this can lead to
chronic systemic and pulmonary hypertension (Adegunsoye,
Ramachandran, 2012).
Chronic systemic hypertension is known to negatively affect
cardiovascular health and increase mortality. It has also been
reported that hypertension in individuals with untreated OSA is
SDUWLFXODUO\GLIÀFXOWWRFRQWURODQGWKDWLQDWWHPSWLQJWRFRQWURO
the high blood pressure, beta blockers are the most effective,
suggesting that a major contributing factor to the high blood
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pressure is sympathetic stimulation (Leung, Bradley, 2001).
Even in the absence of chronic hypertension development,
there is, concern of vascular endothelial dysfunction. Overstimulation of the sympathetic nervous system can, in of itself,
lead to vascular endothelial dysfunction. The pathophysiology of
the damage is, similar to what is found in patients with chronic
hypertension: Vasoconstriction creates more resistance in the
blood vessels. Resistance, especially if prolonged, can cause
damage to the vasculature and lead to hardening of the blood
vessels (Adegunsoye, Ramachandran, 2012). The damage can
EHTXLWHVLJQLÀFDQWEHFDXVHWKHHIIHFWVRIV\PSDWKHWLFV\VWHP
over-stimulation linger into the wake hours as well (Tkacova,
et.al. 2014).
The constant presence of catecholamine levels also puts the
untreated OSA patient at greater risk for thromboembolism
because high levels of catecholamines tends to lead to platelet
aggregation. This and other phenomena which can predispose
an individual to thromboembolism can be reversed with effective treatment. The reversal of which suggests that the hypercoagulability in individuals with OSA is indeed caused by the OSA
(Adegunsoye, Ramachandran, 2012).
There is a secondary problem associated with untreated OSA
of the sleep deprived individual. The way the body clears the
obstructed breathing is by jolting the person out of deep sleep
long enough to return muscle tone to the airway and open it
back up. This arousal from deep sleep is called a Respiratory
Effort- Related Arousal or RERA. A RERA can be present even
LQWKHDEVHQFHRIDFOLQLFDOO\GHÀQHGDSQHDIRUH[DPSOHLIWKH
breathing stops for less than 10 seconds, or if there is no sigQLÀFDQWR[\JHQGHVDWXUDWLRQGXULQJDQHYHQW 7VDUDHWDO 
There are serious health risks associated with sleep deprivation
as well as physiological effects and secondary risks. Psychological
effects could include depression, apathy, and irritably. Secondary
risks could include general fatigue or falling asleep while driving
(Adegunsoye, Ramachandran, 2012).
Sleep deprivation and hypoxia are both known causes of inÁDPPDWLRQ,QÁDPPDWLRQLVDQLQGHSHQGHQWIDFWRULQHQGRWKHlial cell dysfunction and has also been linked to certain cancers
/XLHWDO 6HYHUDOIDFWRUVZKLFKFDXVHLQÁDPPDWLRQDUH
found in high levels in individuals with untreated OSA. Proper
WUHDWPHQW LV HIIHFWLYH LQ VWRSSLQJ WKH LQÁDPPDWRU\ UHVSRQVH
(Adegunsoye, Ramachandran, 2012, Shamsuzzaman, et.al. 2003).
Another factor associated with OSA which causes sleep
deprivation is nocturia. Nocturia is a condition where an individual’s sleep is interrupted multiple times in order to empty the
bladder. The pathophysiology of this condition is that attempting to breathe with an obstructed airway causes an enormous
amount of intrathoracic pressure which results in a much larger
than usual volume of blood to enter the heart. In some individuDOVWKLVRYHUÀOOLQJFDXVHVWKHUHOHDVHRIDWULDOQDXWXUHWLFSHSWLGH
(ANP). ANP in turn causes the kidneys to excrete more water.

7KHUHDVRQWKLVV\VWHPLVDFWLYDWHGLVEHFDXVHWKHRYHUÀOOLQJRI
blood in the heart mimics the mechanics of increased blood
volume. Increased blood volume increases blood pressure. As a
result, the body, thinking that it has too much blood, will want
to get rid of the excess volume by way of diuresis (Umlauf, et.al.
2004). Patients with OSA report that their nocturia subsides
once they comply with effective treatment (Personal communication with patients).
In addition to the mimicking of increased blood volume which
causes the release ANP, ANP excretion is also increased due to
acidosis.The lack of oxygen caused by OSA can certainly lead to
at least a temporary acidosis, and this may further contribute to
nocturia. ANP also directly inhibits the excretion of vasopressin. Vasopressin normally plays a role in the decrease in urine
production while asleep. If vasopressin is inhibited, then urine
production will not decrease and the individual may experience
nocturia. In one study of carefully selected individuals diagnosed
with OSA, blood levels of ANP, as well as urine levels of ANP and
increased urine volume were directly correlated with untreated
OSA. It is also noteworthy that an elevated level of blood ANP
is related to mortality rates in patients with heart problems, and
a correlation between heart disease and untreated OSA has
been strongly established (Umlauf, et.al. 2004).
Nocturia is often associated with aging. This association is
due to the general aging process, and in men due to prostate
hypertrophy, and in women due to decreased bladder volume.
Aging is also a risk factor for OSA, and as such, its another
possible cause of the increase in nocturia with age in both men
and women. The connection between untreated OSA and nocturia is one way to explain why, in many individuals, nocturia is
not resolved with the treatment for benign prostate hypertrophy. It has also been documented that the incidence of sleep
apnea doubles in women post menopause- probably as a result
of low estrogen levels. This correlates well with the increase
in nocturia in women post menopause. Attributing nocturia in
post-menopausal women to untreated OSA may be more accurate than attributing it to a simple decrease in bladder volume.
7KHHIIHFWVRIRYHUHOLPLQDWLRQRIÁXLGVDQGKRZWKLVPD\DIIHFW
SURSHUK\GUDWLRQDQGJHQHUDOÁXLGPDQDJHPHQWLQWKHERG\DOVR
needs to be considered when evaluating the impact of nocturia
(Umlauf, et.al. 2004).
Many individuals with OSA are obese. Obesity is a risk factor
in OSA, but OSA can, in of itself, also cause weight gain. Weight
gain can be attributed to lack of physical activity. People with
OSA often experience chronic fatigue, and this can possibly
cause OSA patients to limit their physical activity. However, in
addition to this secondary cause for weight gain, OSA can be
directly responsible for altered metabolic factors which lead
to obesity. Leptin levels are often found to be at abnormally
high levels in obese individuals. Patients with untreated OSA
often have even higher levels of leptin than obese individuals.
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The current understanding is that leptin is found at high levels because of resistance to their appetite suppressing activity.
Patients with untreated OSA have sometimes been found to
have high levels of leptin and gain weight in the year prior to
diagnosis, and these patients tend to return to normal leptin
levels and lose the weight once proper treatment is undertaken.
It is also noteworthy that a high leptin level is considered a risk
factor for cardiovascular disease (Adegunsoye, Ramachandran,
2012, Shamsuzzaman, et.al. 2003, Milleron, et.al. 2004).
Another metabolic factor linked to OSA is impaired glucose tolerance. Insulin resistance has been directly correlated
to OSA, and several studies demonstrate that individuals with
OSA are several times more likely to develop diabetes mellitus
than those without OSA (Adegunsoye, Ramachandran, 2012,
Gottlieb, et.al. 2010, Bayram, et.al. 2009).
One of the most extensive areas of study concerning untreated OSA is the effect it has on the heart. In fact, about 50% of patients with heart failure have OSA, and medication for heart failure seems to have little, if no effect on alleviating OSA (Bradley,
Floras, 2003). In addition to the effect of pulmonary hypertension on the heart (discussed above), there are additional ways in
which untreated OSA can cause cardiac health problems. When
the body tries to breath while the airway is obstructed, an enormous amount of negative pressure is generated in the thoracic
cavity. This negative pressure pulls large amounts of blood from
the superior and inferior vena cava into the right atrium of
the heart, thus effectively increasimg afterload (Shekerdemian,
Bohn, 1999). The negative intrathoracic pressure increases venous return and distends the right ventricle which effectively
LPSDLUVOHIWYHQWULFXODUÀOOLQJ %UDGOH\)ORUDV $GGLWLRQDOO\
the negative pressure may prevent the left ventricle from reOD[LQJ DQG ÀOOLQJ SURSHUO\ 6KDPVX]]DPDQ HWDO  7KHVH
mechanisms effectively decrease cardiac output (Adegunsoye,
Ramachandran, 2012, Mooe, et.al. 2001, Gottlieb, et.al. 2010).
Individuals with OSA can thus have high blood pressure due to
vasoconstriction from sympathetic nervous system stimulation
but decreased cardiac output due to impaired left ventricular
ÀOOLQJ8QQDWXUDOFRQÀJXUDWLRQRIWKHKHDUWDQGDRUWLFVWUHWFKLQJ
are also caused by this large negative pressure. This stress on
the heart can cause either rapid or reduced heart rate, and
even complete sudden heart failure. The longer the apneic episode the greater the risk of cardiac malfunction (Adegunsoye,
Ramachandran, 2012).
$VLGHIURPUK\WKPLFDQGÀOOLQJSUREOHPVIRUWKHKHDUWWKHUH
is also a risk for myocardial hypertrophy which can cause irreversible hypertension. The hypertrophy is caused by the constant strain on the heart muscle- just as constant strain on any
muscle leads to muscle growth. If the strain is primarily right
sided, then the hypertrophy will affect the right side of the heart.
If the strain is primarily left sided then it will affect the left side
of the heart. If the strain is on both sides then the entire heart
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can be effected. Hypertension caused by OSA can last beyond
the actual apnea episodes, and even in the absence of myocardial hypertrophy, this hypertension can last for many hours after
awakening (Peppard, et.al. 2000, Peker, et.al. 2002). However,
treatment for OSA can often reverse systemic and pulmonary
hypertension if myocardial hypertrophy has not yet set in. This
is one on the many reasons why it’s important to properly treat
OSA at the earliest opportunity (Adegunsoye, Ramachandran,
2012, Jean-louis et.al. 2010).
In addition to myocardial hypertrophy, there is concern
that untreated OSA may cause ion channel remodeling in the
heart. This condition can lead to sudden cardiac death (Chahal,
Somers, 2016). Gene expression effecting potassium ion channels was studied by examining mRNA associated with potasVLXPLRQFKDQQHOV,WZDVGLVFRYHUHGWKDWWKHUHZDVVLJQLÀFDQW
altering of several potassium pump genes which may result in an
extended repolarization period. Potassium pumps are needed
to pump positively charged potassium ions across the myocardial cell membranes so that a new muscle contraction can begin.
,IWKH\GRQ·WSXPSLRQVHIÀFLHQWO\WKHQWKLVSHULRGRIUHSRODUization will take longer. One potential problem with this is that
there is a danger of ventricular extrasystole (premature ventricular contraction). This kind of arrhythmia can cause sudden
cardiac death. The mechanism for how exactly the OSA causes
the altered gene expression has not been fully elucidated, but it
seems to be multifactorial, including stressors such has hypoxia,
sympathetic stimulation, and increased intrathoracic pressure.
Individuals who undergo treatment for OSA can reverse the
pathologic alterations to the potassium ion channels and regain
proper gene expression for potassium pumps that work correctly (Chahal, Somers, 2016, Bradley, Floras, 2003).
The risk of sudden cardiac death in patients with untreated
OSA is not limited to extrasystole due to ion channel malfunction. In fact, there are quite a few additional mechanisms
by which sudden cardiac death may occur. For example, during
REM sleep, there is a general increase in sympathetic stimulation. (This is in contrast to other stages of sleep where the
sympathetic nervous system is depressed.) The transition from
non-REM to REM thus creates a situation which increases oxygen demand. Experiencing an apnea, with the simultaneously
occurring hypoxia, is thus of greater consequence at this point
in the sleep cycle. This ensuing trauma to the heart can cause
arrhythmias (Chahal, Somers, 2016).
Sudden cardiac death is of even greater concern in the
morning hours because that is typically when the longest REM
period takes place and because the apneas at this point tend
to last for longer periods of time. In addition to the risk of
arrhythmias being increased during this longer REM period,
there is great risk of myocardial infarction or stroke at this
point as well (Mooe, et.al. 2001). In general, blood pressure
rises at different points in the sleep cycle. Individuals with
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untreated OSA often experience an even greater increase in
blood pressure- probably due mainly to the overstimulation
of the sympathetic nervous system. The risk for MI or stroke
is always increased with an increase in blood pressure, and as
such, these individuals will be in the most danger during REM
sleep. The longer REM and the prolonged apneas associated
with it have claimed many lives (Michael Katzoff MD, personal
communication May 2017).
Stimulation of the sympathetic nervous system can also result
in tachycardia which further puts a large demand for oxygen
on the heart at a time when the heart cannot get oxygen due
the apnea. This situation can be even more life-threatening in
patients with coronary artery disease (CAD) (Milleron, et.al.
2004). Additionally, a myocardial infarction or stroke is often
caused by a plaque rupture which is made more likely by the
increase in blood pressure and also because of the intrathoracic pressure caused by the obstructed airway (Chahal, Somers,
2016). In fact, 43-91% of patients who experience a stroke also
have sleep apnea (Leung, Bradley, 2001, Shamsuzzaman, et.al.
2003). It is noteworthy that the rise in intrathoracic pressure
has also been known to cause the rupture of an aortic aneurism
which is typically fatal (Chahal, Somers, 2016).
In patients with pre-existing coronary artery disease (CAD)
there is at least a 60-70% increase in sudden cardiac death or
myocardial infarction when the individual also has untreated
OSA. In addition to heart related problems there is an increase
in cerebral vascular complications such as stroke. The cerebral
vascular complications may result from the increase in the prothrombotic effect connected with untreated OSA as well as
from other factors effecting hemodynamics (Mooe, et.al. 2001,
Peker, et.al. 2002). Fortunately, proper treatment for OSA has
been shown to decrease the number of new cardiac issues or
at least to dramatically slow the rate of coronary artery disease
progression (Milleron, et.al. 2004, Peker, et.al. 2002, Jean-louis
HWDO ,WLVOLNHO\WKDWWUHDWPHQWZRXOGEHVLPLODUO\EHQHÀcial to cerebral vascular health (Gottlieb, et.al. 2010).
In general, the sympathetic system stimulation, which often
lingers throughout the day in untreated OSA individuals, is
known to increase platelet aggregation.This aggregation is detrimental to patients with CAD (Milleron, et.al. 2004). Additionally,
SURORQJHGSODWHOHWDJJUHJDWLRQDVZHOODVLQFUHDVHGOHYHOVRIÀEULQRJHQDQGJHQHUDOLQÁDPPDWLRQLQLQGLYLGXDOVZLWKXQWUHDWHG
OSA, may be a risk factor in developing a deep vein thrombosis
on top of the risk these factors pose to CAD (Milleron, et.al.
2004, Bayram, et.al. 2009).
It is noteworthy that many patients with nocturnal angina
experience relief when undergoing proper treatment for OSA.
This suggests that the cause of pain, which is normally due to a
lack of oxygen, is caused by the OSA and is effectively treated
with standard CPAP therapy (Peker, et.al. 2002).
Another area of recent study is the possible connection

between untreated OSA and dementia. One study found that
the correlation between sleep apnea and dementia may be affected by factors such as age, gender, and duration of the condition. The mechanism for the connection between untreated
OSA and dementia are not yet conclusive, but the connection
between hypoxia, which is a side effect of untreated OSA, and
neurological malfunction has been documented a number of
times. For instance, rats which were exposed to hypoxic conditions experienced a greater incidence of apoptosis in their
hippocampus, and advanced brain imaging showed reduced grey
matter in parts of the brain responsible for executive functions
and memory. Damage to these areas in humans may be a factor
in the cause of dementia (Svatikova, et.al. 2003, Ju, et.al. 2013).
$QRWKHUGLVWXUELQJÀQGLQJLVWKDWURGHQWVSODFHGLQK\SR[LF
conditions developed large amounts of cerebral amyloid plaque.
Similar results have been found in humans with levels of serum
amyloid A being two and a half times higher in patients with
untreated OSA (Svatikova, et.al. 2003, Ju, et.al. 2013). Cerebral
DP\ORLGSODTXHLVRQHRIWKHKDOOPDUNÀQGLQJVLQLQGLYLGXDOVZLWK
$O]KHLPHU·VGLVHDVH,WZDVDOVRIRXQGWKDWWKHUHZDVVLJQLÀFDQW
phosphorylation of the tau proteins. Tau proteins are abundant
in neural tissue and function in support of microtubules. When
they are over-phosphorylated, they can malfunction and cause
the structure of the cells in which they are found to become
pathologically altered. Additionally, microtubules function as a
sort of road or transport pathway for various particles within
the cell. The intracellular functions which rely on these transport pathways may stop working properly if the tau proteins
become over phosphorylated. Quite tellingly, another common
ÀQGLQJLQ$O]KHLPHU·VGLVHDVHLVWDXSURWHLQSKRVSKRU\ODWLRQ,Q
lab mice, cerebral amyloid plaque buildup and tau phosphorylation has been connected to decreased memory function
(Daulatzai, 2015). It is also possible that the general damage to
the vasculature throughout the body due to hypoxia can be a
factor in dementia because the vasculature in the brain is negatively affected (Chang, et.al. 2013).
It has been shown that treatment of OSA in the early stages
of Alzheimer’s disease can aid in dramatically slowing its progression. One study demonstrated that with treatment of OSA
with CPAP machine, memory and mental processing speed improved in any stage of dementia. Treatment also helped reduce
RUHOLPLQDWHQHXURLQÁDPPDWLRQ$GGLWLRQDOO\WKHFDUGLRYDVFXODU
improvements experienced with CPAP treatment have had positive impact on patients with neurological illnesses. Conversely,
some research indicates that the onset of mental decline may
begin as much as one decade earlier in individuals with untreated OSA (Emamian, et.al. 2016).
Another connection between sleep apnea and brain function
loss in humans is the presence of a common gene known as
APOE4 (apolipoprotein epsilon 4) which has been shown to
play a role in obstructive sleep apnea as well as being connected
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to the development of dementia. The association could be a
shared genetic fate, but it could also suggest that the gene is tied
mainly to the development of OSA which, if left untreated, could
lead to the damage which can cause dementia. Further studies
would be necessary to determine the exact nature of the correlation. The long-term effects of sleep deprivation caused by
sleep apnea should be considered when determining the longterm effects of untreated OSA on brain function (Chang, et.al.
2013).
A recent study has implicated untreated OSA as one possible
cause of Parkinson’s disease. The mechanisms seem most likely
to include the general oxidative stress caused by hypoxia and
UHSHUIXVLRQDQGWKHJHQHUDOLQÁDPPDWLRQFKDUDFWHULVWLFRIWKH
body’s response to untreated sleep apnea. There is even evidence to support the possibility that the blood brain barrier
may be interrupted as a result of cerebral vascular damage
which may allow molecules harmful to brain tissue to cross the
barrier and reach cells involved in Parkinson’s disease and other
neurological pathologies (Sheu, et.al. 2015).

to his pulmonology and sleep medicine practices and patiently
explained to me the foundational principals of OSA along with
many of its intricate details and its relationship to many bodily
systems which it can affect.

Conclusion

Chang WP, Liu ME, Chang WC, et al. Sleep apnea and the risk of
dementia: a population-based 5-year follow-up study in Taiwan. PLoS
ONE. 2013;8(10):e78655.Costanzo MR, Khayat R, Ponikowski P, et
al. Mechanisms and clinical consequences of untreated central sleep
apnea in heart failure. J Am Coll Cardiol. 2015;65(1):72-84.

Extensive research reveals that untreated obstructive sleep apnea
is extremely traumatic and damaging to the body. It has been
clearly linked to physical diseases in the heart, brain, endocrine
system, and vasculature, and it has been implicated as a cause for
psychological and emotion distress, as well as secondary hazards.
Mortality rates are consistently higher and earlier in individuals
with untreated OSA and as such, individuals presenting to their
KHDOWK FDUH SURYLGHUV ZLWK VLJQLÀFDQW KHDOWK LVVXHV DVVRFLDWHG
with OSA should be tested for it. It is extremely important for
health care providers to realize the severity of OSA and to understand that it can be present even in patients who experience
few of the symptoms commonly indicative of OSA. Even patients
with a relatively low AHI of about 4 or 5 are at risk because
the trauma to the body is consistent and repeated every time
the person sleeps, and this trauma has a tendency to have a cumulative effect on the body. Early diagnosis is key because the
negative effects of OSA can be eliminated with early treatment.
Treatment should be adamantly encouraged even in individuals in
whom permanent damage has already occurred because treatment can reverse some of the damage and certainly help stabilize
the patient and prevent the progression of further health issues.
Unfortunately, the symptoms of sleep apnea are not always connected immediately to the condition and are often written off as
symptoms of other medical or phycological issues. It is therefore
prudent of heath care practitioners to be mindful of sleep apnea
and diagnose it as early as possible.
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